Breath biopsy, a novel technology to identify head and neck squamous cell carcinoma: A systematic review.


Journal

Oral diseases
ISSN: 1601-0825
Titre abrégé: Oral Dis
Pays: Denmark
ID NLM: 9508565

Informations de publication

Date de publication:
Nov 2023
Historique:
revised: 22 06 2022
received: 21 03 2022
accepted: 05 07 2022
medline: 7 12 2023
pubmed: 9 7 2022
entrez: 8 7 2022
Statut: ppublish

Résumé

Head and neck cancers are a heterogeneous group of neoplasms, which together comprise the sixth most common cancer globally. Breath biopsies are a non-invasive clinical investigation that detect volatile organic compounds (VOCs) in exhaled breath. This systematic review examines current applications of breath biopsy for the diagnosis of head and neck squamous cell carcinoma (HNSCC), including data on efficacy and utility, and speculates on the future uses of this non-invasive detection method. Medline, PubMed, Web of Science, Cochrane and Scopus, as well as the grey literature were searched using a search strategy developed to identify relevant studies on the role of breath biopsy in the diagnosis of HNSCC. All included studies were subject to a thorough methodological quality assessment. The initial search generated a total of 1443 articles, 20 of which were eligible for review. A total of 660 HNSCC samples were investigated across the included studies. 3,7-dimethylundecane and benzaldehyde were among several VOCs to be significantly correlated with the presence of HNSCC compared to healthy controls. We show that current breath biopsy methods have high accuracy, specificity and sensitivity for identifying HNSCC. However, further studies are needed given the reported poor quality of the included studies.

Identifiants

pubmed: 35801385
doi: 10.1111/odi.14305
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Pagination

3034-3048

Informations de copyright

© 2022 The Authors. Oral Diseases published by Wiley Periodicals LLC.

Références

Abderrahman, B. (2019). Exhaled breath biopsy: A new cancer detection paradigm. Future Oncology, 15, 1679-1682.
Amann, A., Corradi, M., Mazzone, P., & Mutti, A. (2011). Lung cancer biomarkers in exhaled breath. Expert Review of Molecular Diagnostics, 11, 207-217.
Belizário, J. E., Faintuch, J., & Malpartida, M. G. (2021). Breath biopsy and discovery of exclusive volatile organic compounds for diagnosis of infectious diseases. Frontiers in Cellular and Infection Microbiology, 10, 10.
Bouza, M., Gonzalez-Soto, J., Pereiro, R., de Vicente, J. C., & Sanz-Medel, A. (2017). Exhaled breath and oral cavity VOCs as potential biomarkers in oral cancer patients. Journal of Breath Research, 11, 016015.
Chandran, D., Ooi, E. H., Watson, D. I., Kholmurodova, F., Jaenisch, S., & Yazbeck, R. (2019). The use of selected ion flow tube-mass spectrometry technology to identify breath volatile organic compounds for the detection of head and neck squamous cell carcinoma: A pilot study. Medicina, 55, 306.
Chernov, V. I., Choynzonov, E. L., Kulbakin, D. E., Obkhodskaya, E. V., Obkhodskiy, A. V., Popov, A. S., Sachkov, V. I., & Sachkova, A. S. (2020). Cancer diagnosis by neural network analysis of data from semiconductor sensors. Diagnostics, 10, 677.
Chow, L. Q. (2020). Head and neck cancer. New England Journal of Medicine, 382, 60-72.
Cristaldi, M., Mauceri, R., Di Fede, O., Giuliana, G., Campisi, G., & Panzarella, V. (2019). Salivary biomarkers for Oral squamous cell carcinoma diagnosis and follow-up: Current status and perspectives. Frontiers in Physiology, 10, 1476.
D'Amico, A., Pennazza, G., Santonico, M., Martinelli, E., Roscioni, C., Galluccio, G., Paolesse, R., & Di Natale, C. (2010). An investigation on electronic nose diagnosis of lung cancer. Lung Cancer, 68, 170-176.
de Lacy, C. B., Amann, A., Al-Kateb, H., Flynn, C., Filipiak, W., Khalid, T., Osborne, D., & Ratcliffe, N. M. (2014). A review of the volatiles from the healthy human body. Journal of Breath Research, 8, 014001.
de Leon-Martínez, L. D., Rodríguez-Aguilar, M., Gorocica-Rosete, P., Domínguez-Reyes, C. A., Martínez-Bustos, V., Tenorio-Torres, J. A., Ornelas-Rebolledo, O., Cruz-Ramos, J. A., Balderas-Segura, B., & Flores-Ramírez, R. (2020). Identification of profiles of volatile organic compounds in exhaled breath by means of an electronic nose as a proposal for a screening method for breast cancer: A case-control study. Journal of Breath Research, 14, 046009.
Dharmawardana, N., Goddard, T., Woods, C., Watson, D. I., Butler, R., Ooi, E. H., & Yazbeck, R. (2020a). Breath methane to hydrogen ratio as a surrogate marker of intestinal dysbiosis in head and neck cancer. Scientific Reports, 10, 1-8.
Dharmawardana, N., Goddard, T., Woods, C., Watson, D. I., Ooi, E. H., & Yazbeck, R. (2020b). Development of a non-invasive exhaled breath test for the diagnosis of head and neck cancer. British Journal of Cancer, 123, 1775-1781.
Du, E., Mazul, A. L., Farquhar, D., Brennan, P., Anantharaman, D., Abedi-Ardekani, B., Weissler, M. C., Hayes, D. N., Olshan, A. F., & Zevallos, J. P. (2019). Long-term survival in head and neck cancer: Impact of site, stage, smoking, and human papillomavirus status. Laryngoscope, 129, 2506-2513.
Fielding, D., Hartel, G., Pass, D., Davis, M., Brown, M., Dent, A., Agnew, J., Dickie, G., Ware, R. S., & Hodge, R. (2020). Volatile organic compound breath testing detects in-situ squamous cell carcinoma of bronchial and laryngeal regions and shows distinct profiles of each tumour. Journal of Breath Research, 14, 046013.
García, R. A., Morales, V., Martín, S., Vilches, E., & Toledano, A. (2014). Volatile organic compounds analysis in breath air in healthy volunteers and patients suffering epidermoid laryngeal carcinomas. Chromatographia, 77, 501-509.
Gruber, M., Tisch, U., Jeries, R., Amal, H., Hakim, M., Ronen, O., Marshak, T., Zimmerman, D., Israel, O., & Amiga, E. (2014). Analysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: A feasibility study. British Journal of Cancer, 111, 790-798.
Guenette, J. P. (2021). Radiologic evaluation of the head and neck cancer patient. Hematology/Oncology Clinics of North America, 35, 863-873.
Gupta, B., & Johnson, N. W. (2014a). Emerging and established global life-style risk factors for cancer of the upper aero-digestive tract. Asian Pacific Journal of Cancer Prevention, 15, 5983-5991.
Gupta, B., & Johnson, N. W. (2014b). Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One, 9, e113385.
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & DeBeer, H. (2011). GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology, 64, 383-394.
Hakim, M., Billan, S., Tisch, U., Peng, G., Dvrokind, I., Marom, O., Abdah-Bortnyak, R., Kuten, A., & Haick, H. (2011). Diagnosis of head-and-neck cancer from exhaled breath. British Journal of Cancer, 104, 1649-1655.
Hartwig, S., Raguse, J. D., Pfitzner, D., Preissner, R., Paris, S., & Preissner, S. (2017). Volatile organic compounds in the breath of oral squamous cell carcinoma patients: A pilot study. Otolaryngology-Head and Neck Surgery, 157, 981-987.
Idrees, M., Farah, C. S., Shearston, K., & Kujan, O. (2021). A machine-learning algorithm for the reliable identification of oral lichen planus. Journal of Oral Pathology & Medicine, 50(9), 946-953.
Idrees, M., Farah, C. S., Sloan, P., & Kujan, O. (2022). Oral brush biopsy using liquid-based cytology is a reliable tool for Oral cancer screening: A cost-utility analysis: Oral brush biopsy for oral cancer screening. Cancer Cytopathology. https://doi.org/10.1002/cncy.22599
Johnson, D. E., Burtness, B., Leemans, C. R., Lui, V. W. Y., Bauman, J. E., & Grandis, J. R. (2020). Head and neck squamous cell carcinoma. Nature Reviews Disease Primers, 6, 1-22.
Johnson, N. W., Gupta, B., Speicher, D. J., Ray, C. S., Shaikh, M. H., Al-Hebshi, N., & Gupta, P. C. (2019a). Etiology and risk factors. In Oral and oropharyngeal cancer (2nd ed., pp. 19-94). CRC Press.
Johnson, N. W., Gupta, B., Speicher, D. J., Ray, C. S., Shaikh, M. H., Al-Hebshi, N., & Gupta, P. C. (2019b). Global epidemiology. In Oral and oropharyngeal cancer (2nd ed., pp. 19-94). CRC Press.
Kerdpon, D., & Sriplung, H. (2001). Factors related to advanced stage oral squamous cell carcinoma in southern Thailand. Oral Oncology, 37, 216-221.
Koch, F. P., Kunkel, M., Biesterfeld, S., & Wagner, W. (2011). Diagnostic efficiency of differentiating small cancerous and precancerous lesions using mucosal brush smears of the oral cavity-A prospective and blinded study. Clinical Oral Investigations, 15, 763-769.
Kusampudi, S., & Konduru, N. (2021). Salivary biomarkers for non-invasive early detection of head and neck cancer. In R. El Assal, D. Gaudilliere, & S. T. Connelly (Eds.), Early detection and treatment of Head & Neck Cancers: Practical applications and techniques for detection, diagnosis, and treatment (pp. 149-166). Springer International Publishing.
Kusukawa, J., Suefuji, Y., Ryu, F., Noguchi, R., Iwamoto, O., & Kameyama, T. (2000). Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma. Journal of Oral Pathology & Medicine, 29, 303-307.
Lang, H. P., Loizeau, F., Hiou-Feige, A., Rivals, J.-P., Romero, P., Akiyama, T., Gerber, C., & Meyer, E. (2016). Piezoresistive membrane surface stress sensors for characterization of breath samples of head and neck cancer patients. Sensors, 16, 1149.
Leroy, R., De Gendt, C., Stordeur, S., Schillemans, V., Verleye, L., Silversmit, G., Van Eycken, E., Savoye, I., Grégoire, V., Nuyts, S., & Vermorken, J. (2019). Head and neck cancer in Belgium: Quality of diagnostic management and variability across Belgian hospitals between 2009 and 2014. Frontiers in Oncology, 9, 1006.
Leunis, N., Boumans, M. L., Kremer, B., Din, S., Stobberingh, E., Kessels, A. G., & Kross, K. W. (2014). Application of an electronic nose in the diagnosis of head and neck cancer. The Laryngoscope, 124, 1377-1381.
Mentel, S., Gallo, K., Wagendorf, O., Preissner, R., Nahles, S., Heiland, M., & Preissner, S. (2021). Prediction of oral squamous cell carcinoma based on machine learning of breath samples: A prospective controlled study. BMC Oral Health, 21, 1-12.
Mertz, L. (2020). The great exhale: Using breath analysis to detect disease. IEEE Pulse, 11, 7-11.
Min Ang, X., Chi Khang Au, P., Kwok, K., Yeon Park, K., Kujan, O., Frydrych, A. M., & Farah, C. S. (2019). Quality of life in patients with oral leukoplakia. Journal of Oral Pathology & Medicine, 48, 574-580.
Mohamed, N., van de Goor, R., El-Sheikh, M., Elrayah, O., Osman, T., Nginamau, E. S., Johannessen, A. C., Suleiman, A., Costea, D. E., & Kross, K. W. (2021). Feasibility of a portable electronic nose for detection of Oral squamous cell carcinoma in Sudan. Healthcare, 9, 534.
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6, e1000097.
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., & Brennan, S. E. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71.
Pai, S. I., & Westra, W. H. (2009). Molecular pathology of head and neck cancer: Implications for diagnosis, prognosis, and treatment. Annual Review of Pathology: Mechanisms of Disease, 4, 49-70.
Patterson, R. H., Fischman, V. G., Wasserman, I., Siu, J., Shrime, M. G., Fagan, J. J., Koch, W., & Alkire, B. C. (2020). Global burden of head and neck cancer: Economic consequences, health, and the role of surgery. Otolaryngology-Head and Neck Surgery, 162, 296-303.
Phillips, M., Cataneo, R. N., Saunders, C., Hope, P., Schmitt, P., & Wai, J. (2010). Volatile biomarkers in the breath of women with breast cancer. Journal of Breath Research, 4, 026003.
Schache, A., Kerawala, C., Ahmed, O., Brennan, P. A., Cook, F., Garrett, M., Homer, J., Hughes, C., Mayland, C., & Mihai, R. (2021). British Association of Head and Neck Oncologists (BAHNO) standards 2020. Journal of Oral Pathology & Medicine, 50, 262-273.
Schmutzhard, J., Rieder, J., Deibl, M., Schwentner, I. M., Schmid, S., Lirk, P., Abraham, I., & Gunkel, A. R. (2008). Pilot study: Volatile organic compounds as a diagnostic marker for head and neck tumors. Head & Neck, 30, 743-749.
Schutte, H. W., Heutink, F., Wellenstein, D. J., van den Broek, G. B., van den Hoogen, F. J., Marres, H. A., van Herpen, C. M., Kaanders, J. H., Merkx, T. M., & Takes, R. P. (2020). Impact of time to diagnosis and treatment in head and neck cancer: A systematic review. Otolaryngology-Head and Neck Surgery, 162, 446-457.
Tirzīte, M., Bukovskis, M., Strazda, G., Jurka, N., & Taivans, I. (2017). Detection of lung cancer in exhaled breath with an electronic nose using support vector machine analysis. Journal of Breath Research, 11, 036009.
van de Goor, R. M., Hardy, J. C., van Hooren, M. R., Kremer, B., & Kross, K. W. (2019). Detecting recurrent head and neck cancer using electronic nose technology: A feasibility study. Head & Neck, 41, 2983-2990.
Van De Goor, R., Leunis, N., Van Hooren, M., Francisca, E., Masclee, A., Kremer, B., & Kross, K. (2017). Feasibility of electronic nose technology for discriminating between head and neck, bladder, and colon carcinomas. European Archives of Oto-Rhino-Laryngology, 274, 1053-1060.
Van de Goor, R., van Hooren, M., Dingemans, A.-M., Kremer, B., & Kross, K. (2018). Training and validating a portable electronic nose for lung cancer screening. Journal of Thoracic Oncology, 13, 676-681.
van de Goor, R. M., van Hooren, M. R., Henatsch, D., Kremer, B., & Kross, K. W. (2020). Detecting head and neck squamous carcinoma using a portable handheld electronic nose. Head & Neck, 42, 2555-2559.
van der Schee, M., Pinheiro, H., & Gaude, E. (2018). Breath biopsy for early detection and precision medicine in cancer. Ecancermedicalscience, 12, ed84.
van Hooren, M. R., Leunis, N., Brandsma, D. S., Dingemans, A.-M. C., Kremer, B., & Kross, K. W. (2016). Differentiating head and neck carcinoma from lung carcinoma with an electronic nose: A proof of concept study. European Archives of Oto-Rhino-Laryngology, 273, 3897-3903.
van Schaijik, B., Wickremesekera, A. C., Mantamadiotis, T., Kaye, A. H., Tan, S. T., Stylli, S. S., & Itinteang, T. (2019). Circulating tumor stem cells and glioblastoma: A review. Journal of Clinical Neuroscience, 61, 5-9.
Waltman, C. G., Marcelissen, T. A., & van Roermund, J. G. (2020). Exhaled-breath testing for prostate cancer based on volatile organic compound profiling using an electronic nose device (Aeonose™): A preliminary report. European Urology Focus, 6, 1220-1225.
Wells, G., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., & Tugwell, P. (2014). Newcastle-Ottawa quality assessment scale cohort studies. University of Ottawa.
Witt, K., Inhestern, J., Guntinas-Lichius, O., & Voss, A. (2012). Application of an electronic nose to detect head and neck cancer from exhaled breath. Biomedical Engineering/Biomedizinische Technik, 57, 1015.
Yang, H.-Y., Wang, Y.-C., Peng, H.-Y., & Huang, C.-H. (2021). Breath biopsy of breast cancer using sensor array signals and machine learning analysis. Scientific Reports, 11, 1-9.

Auteurs

Rachel Kok (R)

UWA Dental School, The University of Western Australia, Perth, Western Australia, Australia.

Bede van Schaijik (B)

UWA Dental School, The University of Western Australia, Perth, Western Australia, Australia.

Newell W Johnson (NW)

Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, UK.

Mohammed Imad Malki (MI)

College of Medicine, QU Health, Qatar University, Doha, Qatar.

Agnieszka Frydrych (A)

UWA Dental School, The University of Western Australia, Perth, Western Australia, Australia.

Omar Kujan (O)

UWA Dental School, The University of Western Australia, Perth, Western Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH